Article in today's New York Times about generic meds vs. the brand-name versions:
http://www.nytimes.com/2009/12/19/health/19patient.html?emc=eta1
In the article, it mentions that insurers argue -- surprise, surprise -- that generics are the same as the brand-name versions. But:
[Two studies...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.